 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Study of XL184 in Adults With Glioblastoma Multiforme |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC Rochester, NY |
 |
07/18/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
 |
Rochester, NY |
 |
04/13/2010 |
 |
 |
 |
Details |
 |
Phase I Study To Test The Safety of TVAX Immunotherapy As A Treatment For Recurrent Grade III/IV Gliomas |
 |
Lenexa, KS |
 |
04/12/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors |
 |
San Francisco, CA |
 |
04/12/2010 |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
03/31/2010 |
 |
 |
 |
 |
 |
Details |
 |
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
 |
Houston, TX |
 |
03/30/2010 |
 |
 |
 |
Details |
 |
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
 |
San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
 |
Duarte, CA Chicago, IL Columbus, OH San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
 |
Los Angeles, CA Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas |
 |
Cincinnati, OH |
 |
01/03/2010 |
 |
 |
 |
Details |
 |
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
 |
Boston, MA |
 |
09/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC |
 |
09/05/2009 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |